Application Nr Approved Date Route Status External Links
ANDA203354 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Pramipexole Dihydrochloride Extended-Release Tablets Are Indicated For The Treatment Of Parkinson's Disease. Pramipexole Dihydrochloride Extended-Release Is A Non-Ergot Dopamine Agonist Indicated For The Treatment Of Parkinson’s Disease (Pd) (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Pramipexole Dihydrochloride PRAMIPEXOLE DIHYDROCHLORIDE ZINC3781664

Comments